Brain scan study of amyloid and brain sugar use
Part of Brain & nervous system, Mental health clinical trials.
This study uses brain imaging to measure two things in the brain—amyloid protein and how the brain uses sugar. It may help researchers better understand early brain changes in people in the ALFA project.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must join and sign the study consent form.
- You must be enrolled in the ALFA project study (participants from the ALFA project).
- You must be able to do a brain MRI and not have any scan-disqualifying findings (like major stroke or a brain tumor).
- Your thinking and memory tests must be normal: MMSE 26+ and CDR score 0.
- You must not have certain major mental health diagnoses (like major depression, generalized anxiety, schizophrenia, or bipolar disorder).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses brain imaging to look for amyloid plaques (abnormal protein deposits) as people age. It may help researchers better understand how these changes develop over time.
This study uses a special PET brain scan tracer to measure “tau” protein clumps in the brain. It’s meant to better understand brain changes in people who are already part of the ALFA research program, and may help researchers connect tau levels with memory and thinking.
This study uses brain scans to see how blood flow and sugar transport work in people with both Alzheimer's disease and type 2 diabetes. It may help doctors understand how these conditions interact and find better treatments.
This study uses brain scans (PET) to look at changes in the brain that may be related to memory problems or Alzheimer's disease. It aims to improve understanding of the disease and may help develop better treatments.
This study uses special MRI scans and a PET scan to look at brain chemistry and sugar use in Alzheimer's disease, frontotemporal dementia, and healthy volunteers. The goal is to find better ways to tell these conditions apart.
This trial looks for signs of Alzheimer’s disease in the brain by using memory and thinking tests, and related study procedures. It may help researchers find better ways to identify Alzheimer’s-related changes earlier.
Hear when a new Alzheimer’s disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.